October 11, 2019
Authored and Edited by Alissa E. Green; Sydney R. Kestle; Elizabeth D. Ferrill
In American Axle & Manufacturing, Inc. v. Neapco Holdings LLC, Appeal No. 2018-1763 (Fed. Cir. Oct. 3, 2019), the Federal Circuit affirmed the district court’s grant of summary judgment, finding American Axle’s claims covering “a method of manufacturing a shaft assembly” patent ineligible under 35 U.S.C. § 101.
The Federal Circuit applied the two-step test set forth in Mayo and Alice. At step one, it held that the claims covered a natural law—Hooke’s Law—noting “the claims’ general instruction to tune a liner amounts to no more than a directive to use one’s knowledge of Hooke’s law.” American Axle argued that the claims covered more than the application of Hooke’s law because they are directed to tuning a liner that attenuates two different vibration modes, something it argued had not been done before. The Court rejected this argument, however, finding neither the claims nor the specification identified a means for tuning the liner in this way and, thus, focused only on the “desired result.” At step two, the Court held that the claims did not recite an inventive concept or identify more than conventional pre- and post-solution activity.
Judge Moore dissented. Judge Moore believed that the majority’s concern with the claims was more about enablement than about patent eligibility. Moreover, Judge Moore believed that the majority conflated the two steps of the Mayo/Alice test, and ignored fact questions at step two regarding whether the claims contain an inventive concept.
Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Federal Circuit IP Blog
When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case
May 14, 2026
Federal Circuit IP Blog
Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay
May 14, 2026
Panel Discussion
May 5, 2026
London
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.